Gabapentin potentiates the antiseizure activity of certain anticonvulsants in DBA/2 mice

European Journal of Pharmacology

Volumn 349, Issue 2-3, 1998, Pages 179-185

  De Sarro, Giovambattista ^a   Spagnolo, Cinzia ^a   Gareri, Pietro ^a   Gallelli, Luca ^a   De Sarro, Angela ^b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Anticonvulsants; Carbamazepine; DBA 2 mouse; Epilepsy; Felbamate; Gabapentin; Phenytoin; Seizures audiogenic; Valproate

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; DIAZEPAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; AUDIOGENIC SEIZURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; ENZYME IMMUNOASSAY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACETIC ACIDS; ACOUSTIC STIMULATION; AMINES; ANIMALS; ANTICONVULSANTS; CYCLOHEXANECARBOXYLIC ACIDS; DRUG SYNERGISM; FEMALE; GAMMA-AMINOBUTYRIC ACID; MALE; MICE; MICE, INBRED DBA; SEIZURES;

EID: 0032557663     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00193-9     Document Type: Article

References (33)

1. The International Gabapentin Study Group, Anhut H., Ashman P., Fenerstein T.J., Sauermann W., Saunders M., Schmidt B. Gabapentin (neurotonin) as add-on therapy in patients with partial seizures: a double-blind, placebo controlled study. Epilepsia. 35:1994;795-801.
2. Bartoszyk, G.D., Meyerson, N., Reimann, W., Satzinger, G., vonHodenberg, A., 1986. Gabapentin. In: Meldrum, B.S., Porter, R.J., (Eds.), New Anticonvulsant Drugs. John Libbey, London, pp. 147-163.
3. Basim M., Uthman E.J., Hammond E.J., Wilder B.J. Absence of gabapentin and valproate interaction: an evoked potential and pharmacokinetic study. Epilepsia. 31:1990;645.
4. De Sarro G.B., Croucher M.J., Meldrum B.S. Anticonvulsant actions of DS 103-282: Pharmacological studies in rodents and the baboon Papio papio. Neuropharmacology. 23:1984;526-530.
5. De Sarro G.B., De Sarro A., Trimarchi G.R., Nisticò G. Effects of some calcium antagonists upon the activity of common antiepileptic compounds on sound-induced seizures in DBA/2 mice. Gen. Pharmacol. 23:1992;75-82.
6. De Sarro G.B., Nava F., Aguglia V., De Sarro A. Lamotrigine potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice. Neuropharmacology. 35:1996;153-158.
7. Dunham N.W., Miya T.S. A note on a simple apparatus for detecting neurological deficit in rats and mice. J. Am. Pharm. Assoc. 46:1957;208-209.
8. 2δ subunit of a calcium channel. J. Biol. Chem. 271:1996;5768-5776.
9. Graves N.M., Holmes G.B., Leppik I.E., Rask C., Slavin M., Anhut H. Pharmacokinetics of gabapentin in patients treated with phenytoin. Pharmacotherapy. 9:1989;196.
10. Graves N.M., Leppik I.E., Wagner M.L., Spencer M.M., Erdman G.R. Effect of gabapentin on carbamazepine levels. Epilepsia. 31:1990;644-645.
11. 3H ] gabapentin to a novel site in rat brain: autoradiographic studies Eur. J. Pharmacol. Mol. Pharmacol. 244:1993;303-309.
12. Hooper W.D., Kavanagh M.C., Herkes G.K., Eadie M.J. Lack of pharmacokinetic interaction between phenobarbital and gabapentin. Br. J. Clin. Pharmacol. 31:1991;171-174.
13. Litchfield J.T., Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:1949;99-113.
14. Loscher W., Honack D., Taylor C.P. Gabapentin increases aminoxyacetic acid-induced GABA accumulation in several regions of rat brain. Neurosci Lett. 128:1991;150-154.
15. Macdonald, R.L., Meldrum, B.S., 1995. Principles of antiepileptic drug action. In: Levy, R.H., Mattson, R.H., Meldrum, B.S. (Eds.), Antiepileptic Drugs, 4th edn. Raven Press, New York, 1995, pp. 61-77.
16. McLean M.J. Clinical pharmacokinetics of gabapentin. Neurology. 44:1994;S17-S22.
17. McLean, M.J, 1995. Gabapentin. Chemistry, Absorption, distribution and excretion. In: Levy, R.H., Mattson, R.H., Meldrum, B.S. (Eds.), Antiepileptic Drugs, 4th edn. Raven Press, New York, 1995, pp. 843-849.
18. McLean M.J., MacDonald R.L. Sodium valproate, but not ethosuximide, produces use and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture. J. Pharmac. Exp. Ther. 244:1986;789-795.
19. Meldrum B.S. Amino acid neurotransmitters and new approaches to anticonvulsant drug action. Epilepsia. 25:1984;S140-S149.
20. 3H ]alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding sites J. Neurochem. 54:1990;686-695.
21. Petroff O.A.C., Rothman D.L., Behar K.L., Lamoureux D., Mattson R.H. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Ann. Neurol. 39:1996;95-99.
22. Radulovic L.L., Wilder B.J., Leppik I.E., Boekbrader H.N., Chang T., Posvar E.L., Sedman A.J., Uthman B.M., Erdman G.R. Lack of interaction of gabapentin with carbamazepine or valproate. Epilepsia. 35:1994;155-161.
23. Richens, A., 1993. Clinical pharmacokinetics of gabapentin. New trends in epilepsy management: the role of gabapentin. International Congress and Symposium Series, Vol. 198, pp. 41-46.
24. Rizzo M., Morrone L., Longo P., Sinopoli V.A., Spagnolo C., Lo Pilato R., Pelaggi T., David E., Rotiroti D.A., De Sarro G. Simultaneous determination of lamotrigine, felbamate and some conventional antiepileptic drugs using high-performance liquid chromatography. Pharmacol. Res. 35:1997;105.
25. Rock D.M., Kelly K.M., MacDonald R.L. Gabapentin actions on ligand and voltage-gated response in cultured rodent neurons. Epilepsy Res. 16:1993;89-98.
26. Stewart B.H., Kugler A.R., Thompson P.R., Bockbrader H.N. A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma. Pharm. Res. 10:1993;296-301.
27. 3H ]gabapentin binding to a novel site in rat brain: homogenate binding studies Eur. J. Pharmacol. Mol. Pharmacol. 244:1993;293-301.
28. Taylor, C.P., 1995. Gabapentin: Mechanism of action In: Levy, R.H., Mattson, R.H., Meldrum, B.S. (Eds.) Antiepileptic Drugs, 4th edn. Raven Press, New York, pp. 829-842.
29. Taylor C.P., Rock D.M., Weinkauf R.J., Ganong A.H. In vitro and in vivo electrophysiological effects of the anticonvulsant gabapentin. Soc. Neurosci. Abstr. 14:1988;866. abstract.
30. Taylor C.P., Vartanian M.G., Andruszkiewiewicz R., Silverman R.B. 3-Alkyl GABA and 3-alkylglutamic acid analogues: two new classes of anticonvulsant agents. Epilepsy Res. 11:1992;103-110.
31. Taylor C.P., Vartanian M.G., Yuen P.W., Bigge C., Suman-Chauhan N., Dill D.R. Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin. Epilepsy Res. 14:1992;11-15.
32. Upton N. Mechanism of action of new antiepileptic drugs: rationale design and serendipitous findings. Trends Neurosci. 15:1994;456-463.
33. Vollmer K.O., von Hodenberg A., Kolle E.U. Pharmacokinetics and metabolism of gabapentin in rat, dog and man. Arzneim.-Forsch./Drug Res. 36:1986;830-839.